Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period

Gut

Volumn 61, Issue 12, 2012, Pages 1670-1677

  Rohof, W O ^a   Bennink, R J ^a   De Ruigh, A A ^a   Hirsch, D P ^a   Zwinderman, A H ^a   Boeckxstaens, G E ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; PLACEBO;

ACIDITY; ADULT; AGED; ARTICLE; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAPHRAGM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXPOSURE; FEMALE; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; IMPEDANCE; LARGE HIATUS HERNIA; MALE; MANOMETRY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCINTIGRAPHY; SMALL HIATUS HERNIA; STOMACH MOTILITY; TREATMENT RESPONSE;

AGED; AZITHROMYCIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HERNIA, HIATAL; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84868693920     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300926     Document Type: Article

References (39)

1. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1383-91, 1391.
2. Dent J, El-Serag HB, Wallander MA, et al . Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-17. (Pubitemid 40559260)
3. Beaumont H, Bennink RJ, de Jong J, et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 2010;59:441-51.
4. Fletcher J, Wirz A, Young J, et al. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001; 121:775-83. (Pubitemid 32959387)
5. Mittal RK, Lange RC, McCallum RW. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology 1987;92:130-5. (Pubitemid 17207671)
6. Koutsoumbi P, Epanomeritakis E, Tsiaoussis J, et al. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors. Am J Gastroenterol 2000;95:3388-92.
7. Abu-Gharbieh E, Vasina V, Poluzzi E, et al. Antibacterial macrolides: a drug class with a complex pharmacological profile. Pharmacol Res 2004;50:211-22. (Pubitemid 38844473)
8. Mertens V, Blondeau K, Pauwels A, et al. Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients. Dig Dis Sci 2009;54:972-9.
9. Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996;110:1982-96.
10. Kuiken S, Van Den Elzen B, Tytgat G, et al. Evidence for pooling of gastric secretions in the proximal stomach in humans using single photon computed tomography. Gastroenterology 2002; 123:2157-8. (Pubitemid 35408338)
11. Bredenoord AJ, Weusten BL, Timmer R, et al . Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux. Gastroenterology 2006; 130:334-40.
12. van Herwaarden MA, Samsom M, Smout AJ. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology 2000; 119:1439-46.
13. Boeckxstaens GE, Beaumont H, Mertens V, et al. Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease. Gastroenterology 2010;139:409-17.
14. Beaumont H, Smout A, Aanen M, et al . The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study. Aliment Pharmacol Ther 2009;30:937-46.
15. Rohof WO, Lei A, Boeckxstaens GE. Effect of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower esophageal sphincter relaxations and reflux episodes in healthy males. Gastroenterology 2011;140 (S1):S-66.
16. Scheffer RC, Bredenoord AJ, Hebbard GS, et al. Effect of proximal gastric volume on hiatal hernia. Neurogastroenterol Motil 2010;22 :552-6, e120.
17. Jones MP, Sloan SS, Rabine JC, et al. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001;96:1711-17.
18. van Herwaarden MA, Samsom M, Smout AJ. The role of hiatus hernia in gastrooesophageal reflux disease. Eur J Gastroenterol Hepatol 2004;16 :831-5.
19. Sgouros SN, Mpakos D, Rodias M, et al. Prevalence and axial length of hiatus hernia in patients, with nonerosive reflux disease: a prospective study. J Clin Gastroenterol 2007; 41:814-18. (Pubitemid 47442706)
20. Arts J, Caenepeel P, Verbeke K, et al. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut 2005;54:455-60. (Pubitemid 40395493)
21. Coulie B, Tack J, Peeters T, et al. Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut 1998; 43:395-400. (Pubitemid 28414922)
22. Sifrim D, Matsuo H, Janssens J, et al. Comparison of the effects of midecamycin acetate and azithromycin on gastrointestinal motility in man. Drugs Exp Clin Res 1994; 20:121-6. (Pubitemid 24211103)
23. Annese V, Janssens J, Vantrappen G, et al. Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination. Gastroenterology 1992;102:823-8.
24. Kahrilas PJ, Lin S, Chen J, et al. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut 1999;44:476-82. (Pubitemid 29169946)
25. Pandolfino JE, Kim H, Ghosh SK, et al. High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD. Am J Gastroenterol 2007; 102:1056-63. (Pubitemid 46698234)
26. Pandolfino JE, Shi G, Trueworthy B, et al. Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects. Gastroenterology 2003;125:1018-24. (Pubitemid 37193448)
27. Boecxstaens V, Bisschops R, Blondeau K, et al. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. Aliment Pharmacol Ther 2011; 33:1370-7.
28. Vo L, Simonian HP, Doma S, et al. The effect of rabeprazole on regional gastric acidity and the postprandial cardia/gastro-oesophageal junction acid layer in normal subjects: a randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2005;21 :1321-30. (Pubitemid 40813678)
29. Kwiatek MA, Roman S, Fareeduddin A, et al. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients. Aliment Pharmacol Ther 2011;34:59-66.
30. Bruley des Varannes S, Parys V, Ropert A, et al. Erythromycin enhances fasting and postprandial proximal gastric tone in humans. Gastroenterology 1995;109:32-9.
31. Ruth M, Hamelin B, Rohss K, et al. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1998;12 :35-40. (Pubitemid 28057402)
32. Kim YS, Kim TH, Choi CS, et al. Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study. World J Gastroenterol 2005;11 :4210-14.
33. van Herwaarden MA, Samsom M, Van Nispen CH, et al. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. Aliment Pharmacol Ther 2000;14:453-62.
34. Netzer P, Schmitt B, Inauen W. Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002;16 :1481-90. (Pubitemid 34953589)
35. Champion G, Richter JE, Singh S, et al. Effects of oral erythromycin on esophageal pH and pressure profiles in patients with gastroesophageal reflux disease. Dig Dis Sci 1994;39:129-37. (Pubitemid 24041720)
36. Talley NJ, Verlinden M, Geenen DJ, et al. Effects of a motilin receptor agonist (ABT- 229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut 2001;49:395-401.
37. van PB, Sigterman KE, Bonis P, et al. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2010;(11):CD002095.
38. Fox M, Kant R, Kaufman E, et al. The mechanism of reflux Suppression by alginates assessed by Magnetic Resonance imaging and manometry. Gastroenterology 2011;140(5 Suppl 1):S576-7.
39. Zentilin P, Dulbecco P, Savarino E, et al. An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pHmetry. Aliment Pharmacol Ther 2005;21:29-34. (Pubitemid 40175341)